Revision history of "Lack of GFR1 encourages hepatocellular carcinoma advancement yet improves oxaliplatinmediated antitumor usefulness"

From EECH Central
Jump to: navigation, search

Diff selection: Mark the radio boxes of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

  • (cur | prev) 10:29, 18 May 2024Lynxfruit9 (Talk | contribs). . (3,702 bytes) (+3,702). . (Created page with "Path studies indicated disturbance of metabolism walkways after GATA6 knockout which include tricarboxylic acid (TCA) period, glycolysis and energy-related protein path ways....")